XML 23 R8.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Class A Common Stock
Class B-1 Common Stock
Class B-2 Common Stock
Cumulative effect of accounting change
Common Stock
Class A Common Stock
Common Stock
Class B-1 Common Stock
Common Stock
Class B-2 Common Stock
Additional Paid-in Capital
 [1]
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Accumulated Deficit
Cumulative effect of accounting change
Beginning Balance (in shares) at Dec. 31, 2019 [1]           200,112,000 44,050,000 44,050,000        
Beginning Balance at Dec. 31, 2019 $ 1,294,933       $ (741) $ 2,000 [1] $ 440 [1] $ 0 [1] $ 2,141,865 $ 5,309 $ (854,681) $ (741)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Stock-based compensation 12,044               12,044      
Repurchase of shares (in shares) [1]           (218,000)            
Payments for dividends related to Class B-2 shares (3,286)         $ (2) [1]     (2,187)   (1,097)  
Settlement of certain vested stock options (7,506)               (7,506)      
Payment for taxes related to net share settlement of equity awards (2,356)               (2,356)      
Issuance of shares upon exercise of vested options (in shares) [1]           523,000            
Issuance of shares upon exercise of vested options and RSUs 3,400         $ 6 [1]     3,394      
Net loss (167,887)                   (167,887)  
Other comprehensive loss 37,986                 37,986    
Ending Balance (in shares) at Dec. 31, 2020 [1]           200,417,000 44,050,000 44,050,000        
Ending Balance at Dec. 31, 2020 1,166,587         $ 2,004 [1] $ 440 [1] $ 0 [1] 2,145,254 43,295 (1,024,406)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Stock-based compensation 44,113               44,113      
Issuance of common stock upon initial public offering, net of underwriting discounts and offering costs (in shares) [1]           33,350,000            
Issuance of common stock upon initial public offering, net of underwriting discounts 903,766         $ 334 [1]     903,432      
Repurchase of shares (in shares) [1]           (420,000)            
Payments for dividends related to Class B-2 shares (9,318)         $ (4) [1]     (4,159)   (5,155)  
Payment for taxes related to net share settlement of equity awards $ (2,825)               (2,825)      
Issuance of shares upon exercise of vested options (in shares) 1,276,000         842,000 [1]            
Issuance of shares upon exercise of vested options and RSUs $ 7,426         $ 9 [1]     7,417      
Net loss (99,929)                   (99,929)  
Other comprehensive loss (26,144)                 (26,144)    
Ending Balance (in shares) at Dec. 31, 2021   234,189,000 44,050,000 44,050,000   234,189,000 [1] 44,050,000 [1] 44,050,000 [1]        
Ending Balance at Dec. 31, 2021 1,983,676         $ 2,343 [1] $ 440 [1] $ 0 [1] 3,093,232 17,151 (1,129,490)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Stock-based compensation 136,469               136,469      
Issuance of common stock upon initial public offering, net of underwriting discounts and offering costs (in shares) [1]           1,925,000            
Issuance of common stock upon initial public offering, net of underwriting discounts 32,790         $ 19 [1]     32,771      
Payments for dividends related to Class B-2 shares $ (24)                   (24)  
Issuance of shares upon exercise of vested options (in shares) 1,665,000         3,635,000 [1]            
Issuance of shares upon exercise of vested options and RSUs $ 19,947         $ 36 [1]     19,911      
Net loss (53,675)                   (53,675)  
Other comprehensive loss (64,822)                 (64,822)    
Ending Balance (in shares) at Dec. 31, 2022   239,749,000 44,050,000 44,050,000   239,749,000 [1] 44,050,000 [1] 44,050,000 [1]        
Ending Balance at Dec. 31, 2022 $ 2,054,361         $ 2,398 [1] $ 440 [1] $ 0 [1] $ 3,282,383 $ (47,671) $ (1,183,189)  
[1] Amounts for periods prior to the completion of our restructuring transactions on September 30, 2021 have been retrospectively adjusted to give effect to the restructuring transactions described in Note 1 Organization and Description of Business in the Notes to our Consolidated Financial Statements.